title: [Graft versus host disease following liver transplantation. Favorable outcome after treatment with tacrolimus].
authors.forename: Jérôme
authors.initials: J
authors.lastname: Dumortier
authors.forename: Pierre
authors.initials: P
authors.lastname: Souraty
authors.forename: Pierre
authors.initials: P
authors.lastname: Bernard
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Scoazec
authors.forename: Françoise
authors.initials: F
authors.lastname: Berger
authors.forename: Sylvie
authors.initials: S
authors.lastname: Euvrard
authors.forename: Olivier
authors.initials: O
authors.lastname: Boillot
mesh_terms: D000328:Adult; D001706:Biopsy; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008104:Liver Cirrhosis, Alcoholic / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus